Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

Coronary artery disease in patients with systemic lupus erythematosus

Abstract

Background A 24-year-old woman with an 11-year history of systemic lupus erythematosus presented with exacerbation of chronic abdominal pain followed by substernal chest pain. She had a history of pericarditis secondary to systemic lupus erythematosus and of varicella-zoster reactivation secondary to immunosuppression. Long-term medications included prednisolone, hydroxychloroquine, aspirin, and mycophenolate mofetil.

Investigations Physical examination, mesenteric angiography, CT of the abdomen, esophagogastroduodenoscopy, colonoscopy, pelvic ultrasound, laboratory testing, serologic testing, cardiac echocardiography, electrocardiography and coronary angiography.

Diagnosis Acute myocardial infarction secondary to severe multivessel atherosclerotic coronary artery disease.

Management Intra-aortic balloon pump followed by emergent four-vessel coronary artery bypass grafting. Aspirin, hydroxychloroquine, and mycophenolate mofetil were continued and a judicious tapering of prednisolone was initiated.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Nikpour M et al. (2005) Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am 31: 329–354

    Article  Google Scholar 

  2. Toloza SMA et al. (2004) Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXIII. Baseline predictors of vascular events. Arthritis Rheum 50: 3947–3957

    Article  Google Scholar 

  3. Fessler BJ et al. (2005) Systemic lupus erythematosus in three ethnic groups XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum 52: 1473–1480

    Article  Google Scholar 

  4. Manzi S et al. (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145: 408–415

    Article  CAS  Google Scholar 

  5. Sella EM et al. (2003) Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus. Ann Rheum Dis 62: 1066–1070

    Article  CAS  Google Scholar 

  6. Kwok Y et al. (1999) Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 83: 660–666

    Article  CAS  Google Scholar 

  7. Jimenez S et al. (2005) Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology 44: 756–761

    Article  Google Scholar 

  8. Asanuma Y et al. (2003) Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 349: 2407–2415

    Article  CAS  Google Scholar 

  9. Birdas TJ et al. (2005) Outcomes of coronary artery bypass grafting in patients with connective tissue diseases. Ann Thorac Surg 79: 1610–1614

    Article  Google Scholar 

  10. Wajed J et al. (2004) Prevention of cardiovascular disease in systemic lupus erythematosus—proposed guidelines for risk factor management. Rheumatology 43: 7–12

    Article  CAS  Google Scholar 

  11. Wahl DG et al. (2000) Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis. Arch Int Med 160: 2042–2048

    Article  CAS  Google Scholar 

  12. Ridker PM et al. (2005) A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352: 1293–1304

    Article  CAS  Google Scholar 

  13. Antithrombotic Trialists' Collaboration (2002) Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324: 71–86

  14. Kang S et al. (2004) Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis. Atherosclerosis 177: 433–442

    Article  CAS  Google Scholar 

  15. Jury EC and Ehrenstein MR (2005) Statins: immunomodulators for autoimmune rheumatic disease? Lupus 14: 192–196

    Article  CAS  Google Scholar 

  16. Kiana A and Petri M (2004) Predictors of statin toxicity in the Lupus Atherosclerosis Prevention Study [abstract]. Arthritis Rheum 50 (Suppl): S406

    Google Scholar 

  17. Petri M et al. (1994) Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 96: 254–259

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Written consent for publication was obtained from the patient reported in this Case Study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eliza F Chakravarty.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galindo, M., Chung, L., Crockett, S. et al. Coronary artery disease in patients with systemic lupus erythematosus. Nat Rev Rheumatol 1, 55–59 (2005). https://doi.org/10.1038/ncprheum0037

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0037

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing